Some areas of are temporarily unavailable. We apologize for the inconvenience and are working to restore access.

  • Clinical Update

    Drug Update: Vyzulta and Rhopressa

    Written By: Annie Stuart, Contributing Writer, interviewing Ahmad A. Aref, MD, Harry A. Quigley, MD, and Robert N. Weinreb, MD

    Now that Rhopressa and Vyzulta are here, what can you expect?